Acrivon Therapeutics Inc (ACRV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
Operating Expenses | 21,437 | 17,668 | 21,053 | 16,137 | 15,520 |
Operating Income | -21,437 | -17,668 | -21,053 | -16,137 | -15,520 |
Other Income | 2,639 | 1,182 | 1,801 | 1,671 | 1,606 |
Pre-tax Income | -18,798 | -16,486 | -19,252 | -14,466 | -13,914 |
Net Income Continuous | -18,798 | -16,486 | -19,252 | -14,466 | -13,914 |
Net Income | $-18,798 | $-16,486 | $-19,252 | $-14,466 | $-13,914 |
EPS Basic Total Ops | -0.52 | -0.73 | -0.87 | -0.66 | -0.63 |
EPS Basic Continuous Ops | -0.52 | -0.73 | -0.86 | -0.66 | -0.63 |
EPS Diluted Total Ops | -0.52 | -0.73 | -0.87 | -0.66 | -0.63 |
EPS Diluted Continuous Ops | -0.52 | -0.73 | -0.86 | -0.66 | -0.63 |
EPS Diluted Before Non-Recurring Items | -0.52 | -0.73 | -0.86 | -0.66 | -0.63 |
EBITDA(a) | $-22,308 | $-18,021 | $-21,584 | $-16,746 | $-16,159 |